儿童缺血性卒中:SARS-CoV-2感染的不常见并发症
该国际队列研究调查了61个儿童卒中中心,发现SARS-CoV-2住院患儿中缺血性卒中比例为0.82%(8/971),而卒中患儿中SARS-CoV-2检测阳性比例较低(新生儿动脉缺血性卒中0.9%,儿童动脉缺血性卒中3.6%),但检测率不足50%,提示儿童卒中为SARS-CoV-2的不常见并发症。
要点
- SARS-CoV-2住院患儿中缺血性卒中发生率为0.82%(8/971)。
- 儿童动脉缺血性卒中患儿中SARS-CoV-2阳性率为3.6%(6/166)。
- 仅30.5%新生儿和60%儿童卒中患者接受了SARS-CoV-2检测。
核心结论
- 儿童卒中为SARS-CoV-2感染的不常见并发症,类似成人。
- 在检测病毒的儿童缺血性卒中患者中,仅4.6%检测到SARS-CoV-2。
研究设计与样本
- 国际多中心调查,覆盖61个具有儿童卒中专业知识的中心。
- 调查2020年3月1日至5月31日期间住院的≤18岁SARS-CoV-2患者及新发新生儿和儿童缺血性卒中病例。
主要发现
- 42个中心报告了SARS-CoV-2住院人数,971例患儿中8例(0.82%)发生缺血性卒中。
- 新生儿动脉缺血性卒中108例中1例(0.9%)SARS-CoV-2阳性;新生儿脑静脉窦血栓33例中0例(0%)。
- 儿童动脉缺血性卒中166例中6例(3.6%)阳性;儿童脑静脉窦血栓54例中1例(1.9%)阳性。
- 经检测的卒中病例中,阳性比例分别为2.9%、0%、6.1%和3.0%。
- 8例SARS-CoV-2阳性卒中患者中7例存在其他已确定的卒中危险因素。
关键数值与推荐
- 儿童SARS-CoV-2住院患者中缺血性卒中比例为0.82%(8/971)。
- 儿童动脉缺血性卒中患者中SARS-CoV-2阳性率为3.6%(6/166)。
- 检测病毒的儿童缺血性卒中患者中SARS-CoV-2阳性率为4.6%。
临床怎么用
- 在大流行持续期间,应考虑对儿童卒中患者进行SARS-CoV-2检测。
- 儿童卒中评估时应同时关注其他已确定的卒中危险因素。
局限性
- 仅30.5%的新生儿和60%的儿童卒中患者接受了SARS-CoV-2检测,阳性比例可能被低估。
- 调查基于自愿报告,可能存在中心间报告差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Severe complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) include arterial ischemic stroke (AIS) in adults and multisystem inflammatory syndrome in children. Whether stroke is a frequent complication of pediatric SARS-CoV-2 is unknown. This study aimed to determine the proportion of pediatric SARS-CoV-2 cases with ischemic stroke and the proportion of incident pediatric strokes with SARS-CoV-2 in the first 3 months of the pandemic in an international cohort. METHODS: We surveyed 61 international sites with pediatric stroke expertise. Survey questions included: numbers of hospitalized pediatric (≤ 18 years) patients with SARS-CoV-2; numbers of incident neonatal and childhood ischemic strokes; frequency of SARS-CoV-2 testing for pediatric patients with stroke; and numbers of stroke cases positive for SARS-CoV-2 from March 1 to May 31, 2020. RESULTS: Of 42 centers with SARS-CoV-2 hospitalization numbers, 8 of 971 (0.82%) pediatric patients with SARS-CoV-2 had ischemic strokes. Proportions of stroke cases positive for SARS-CoV-2 from March to May 2020 were: 1 of 108 with neonatal AIS (0.9%), 0 of 33 with neonatal cerebral sinovenous thrombosis (CSVT; 0%), 6 of 166 with childhood AIS (3.6%), and 1 of 54 with childhood CSVT (1.9%). However, only 30.5% of neonates and 60% of children with strokes were tested for SARS-CoV-2. Therefore, these proportions represent 2.9, 0, 6.1, and 3.0% of stroke cases tested for SARS-CoV-2. Seven of 8 patients with SARS-CoV-2 had additional established stroke risk factors. INTERPRETATION: As in adults, pediatric stroke is an infrequent complication of SARS-CoV-2, and SARS-CoV-2 was detected in only 4.6% of pediatric patients with ischemic stroke tested for the virus. However, < 50% of strokes were tested. To understand the role of SARS-CoV-2 in pediatric stroke better, SARS-CoV-2 testing should be considered in pediatric patients with stroke as the pandemic continues. ANN NEUROL 2021;89:657-665.
引用
- Beslow LA, Linds AB, Fox CK, et al. Pediatric Ischemic Stroke: An Infrequent Complication of SARS-CoV-2. Ann Neurol. 2021. PMID: 33332607. doi:10.1002/ana.25991
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。